Magnera Corp. (MAGN) Market Cap
Magnera Corp. has a market capitalization of $378.1M.
Financials based on reported quarter end 2025-12-27
Price: $10.62
▼ -0.46 (-4.15%)
Market Cap: 378.07M
NYSE · time unavailable
CEO: Curtis L. Begle
Sector: Industrials
Industry: Manufacturing - Textiles
IPO Date: 2004-02-06
Website: http://magnera.com
Magnera Corp. (MAGN) - Company Information
Market Cap: 378.07M · Sector: Industrials
Magnera Corp. engages in a wide range of products, including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products serving the food and beverage industry. The company was founded on November 4, 2024 and is headquartered in Charlotte, NC.
Analyst Sentiment
Based on 1 ratings
Analyst 1Y Forecast: $16.00
Average target (based on 1 sources)
Consensus Price Target
Low
$16
Median
$18
High
$19
Average
$18
Potential Upside: 64.8%
Price & Moving Averages
📘 Full Research Report
AI-Generated Research: This report is for informational purposes only.
Related Companies in Industrials
PARK OHIO HOLDINGS CORP (PKOH)
Industrials
$0.38B
Mkt Cap
CONCRETE PUMPING HOLDINGS INC (BBCP)
Industrials
$0.38B
Mkt Cap
SBC MEDICAL GROUP HOLDINGS INC (SBC)
Industrials
$0.37B
Mkt Cap
RADIANT LOGISTIC INC (RLGT)
Industrials
$0.39B
Mkt Cap
WABASH NATIONAL CORP (WNC)
Industrials
$0.36B
Mkt Cap
QUAD GRAPHICS INC CLASS A (QUAD)
Industrials
$0.39B
Mkt Cap
Fundamentals Overview
📊 AI Financial Analysis
Powered by StockMarketInfo"MAGN reported a revenue of $792M with a net loss of $34M, resulting in a negative EPS of -$0.95. The company demonstrates a robust asset base of $3.893B, although its liabilities of $2.855B lead to a net debt of $1.732B, which indicates a high leverage situation. The operating cash flow is positive at $65M, contributing to a free cash flow of $42M, which is a positive indicator of liquidity despite the operational losses. The market performance has seen significant challenges, with a one-year price decline of approximately 52.57%, reflecting investor concerns about profitability and growth. Dividends have been paid previously, but no dividends were declared in the last reporting period. The current market price of $9.04 has notably decreased, further stressing the potential volatility and risks of investment in this stock. Overall, investor sentiment may remain cautious given the recent performance trends and operating results."
Revenue Growth
Considerable revenue of $792M indicates stable demand.
Profitability
Negative net income signals ongoing profitability challenges.
Cash Flow Quality
Positive operating cash flow, with free cash flow indicating liquidity.
Leverage & Balance Sheet
High debt levels represent significant leverage risks.
Shareholder Returns
Shareholder returns are low due to prior dividend payments, with no recent distributions.
Analyst Sentiment & Valuation
Target price reflects potential upside, but high volatility deters investment.
Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.
Management is confident on 2026 financial trajectory, reaffirming ~9% adjusted EBITDA growth as Project CORE and synergies are 'tracking as planned.' Operationally, they point to North America wipes/adult momentum and a portfolio shift in South America driven by rising adult incontinence adoption (noted at ~20% of the South America personal care portfolio). However, the Q&A exposes several real frictions: Europe demand remains soft (guided ~-3% region, with Q1 at -5%), South America is still dealing with Asia import pressure and Brazil antidumping/countermeasure outcomes (May timeframe), and winter storms reduced North America shipping days by ~10% with timing/catch-up effects into next quarter. Analyst pushback focused on whether PMI/restocking signals in January were translating into actual demand; management stayed cautious, citing they are optimistic but not underwriting restocking into the outlook. Overall tone is upbeat, but the pressure points in Q&A underline uneven regional demand and policy-driven uncertainty.
Growth Catalysts
- Project CORE transformation tracking as planned; synergy realization supporting earnings growth
- North America wipes and adult end markets strength; Spinlace/proprietary tech gaining momentum
- Adult incontinence adoption ramp in South America supported by government subsidies (portfolio shift toward ~20% adult in South America, targeting ~50-50 split over 3-5 years)
- Barrier protection innovation for healthcare that ends need for PFAS chemicals (launched previously; described as transformational)
- Kamisoft platform launched in North America; expanded to remaining regions with mid-single-digit sales growth (from $15m last year)
Business Development
- Customer partnership activity/merger and acquisition intent viewed positively; management indicated increased opportunities for supply-chain efficiencies and differentiation on the shelf
- Advanced materials solution candidate for a government grant tied to regional supply chain priorities for lithium-ion defense/electrification needs
Financial Highlights
- Sales: $792 million (strength in consumer solutions offset by weaker Latin America and broader Europe softness)
- Adjusted EBITDA: $93 million, flat YoY on a constant-currency basis (synergies/cost reductions offset softer Europe and South America demand)
- Rest of World segment Adjusted EBITDA: +9% YoY to $35 million on disciplined cost management and synergy realization
- Americas organic volume: +2% driven by wipes and adult end markets; South America baby business challenged by heightened competitive intensity since Q2 FY2025
- Americas Adjusted EBITDA: -$3 million YoY (attributed largely to South America volume and product mix pressures)
- Antidumping/countermeasure discussion: legislation/proposals in Brazil expected to conclude in May timeframe; measures proposed/expanded to nonwoven materials (management context: potential margin/volume impact risk)
Capital Funding
- Free cash flow (last 4 quarters): $97 million; FCF yield ~18% based on end-of-quarter market cap
- Available liquidity: ~ $550 million at quarter end
- Debt repayment: $27 million repaid during the quarter; expects ~ $100 million debt repayment over fiscal 2026
- Target leverage ratio: 3x (deleveraging priority to strengthen balance sheet)
Strategy & Ops
- Project CORE: investment on prioritized spunbond lines to more premium applications; removing capacity to improve utilization; benefit guide reiterated in range of $15m-$20m (slight Q1 benefit; more actions ramping over remaining quarters)
- Operational hurdle from winter storms (North America): impacted roughly 10% of North America shipping days in first wave; expected some catch-up by end of quarter/next quarter with continued monitoring of freight/logistics
- No major supply chain logistics disruptions reported; product delivery managed with customer pickup/route optimization
Market Outlook
- Full-year 2026 adjusted EBITDA guidance: 9% growth (reinforced as tracking as planned)
- Volume outlook: 'flattish volumes overall' in fiscal 2026; Europe expected ~-3% (management noted -5% in the first quarter) with monitoring and 'appropriate actions'
- South America comps expected to normalize in the back half/last 2 quarters of the fiscal year
Risks & Headwinds
- Europe demand softness persists; management guided to -3% in region (Q1 referenced -5%); not expecting a 'tremendously robust' demand environment
- South America competitive import pressure from Asia; antidumping measures/proposals in Brazil could alter the competitive landscape and timing (expected May conclusion)
- Contractual pass-through of lower raw material costs reduced reported revenues (profitability not materially affected per management)
- Weather/storm risk: 10% of North America shipping days impacted in first wave; additional storm concentration in North Carolina; inventory/logistics management needed for store replenishment
Sentiment: MIXED
Note: This summary was synthesized by AI from the MAGN Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.